These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

855 related articles for article (PubMed ID: 11390617)

  • 1. Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins.
    Latham T; Galarza JM
    J Virol; 2001 Jul; 75(13):6154-65. PubMed ID: 11390617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
    Bright RA; Carter DM; Daniluk S; Toapanta FR; Ahmad A; Gavrilov V; Massare M; Pushko P; Mytle N; Rowe T; Smith G; Ross TM
    Vaccine; 2007 May; 25(19):3871-8. PubMed ID: 17337102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virus-like particle vaccine conferred complete protection against a lethal influenza virus challenge.
    Galarza JM; Latham T; Cupo A
    Viral Immunol; 2005; 18(2):365-72. PubMed ID: 16035948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice.
    Pushko P; Tumpey TM; Bu F; Knell J; Robinson R; Smith G
    Vaccine; 2005 Dec; 23(50):5751-9. PubMed ID: 16143432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural Analysis of the Roles of Influenza A Virus Membrane-Associated Proteins in Assembly and Morphology.
    Chlanda P; Schraidt O; Kummer S; Riches J; Oberwinkler H; Prinz S; Kräusslich HG; Briggs JA
    J Virol; 2015 Sep; 89(17):8957-66. PubMed ID: 26085153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fabrication of influenza virus-like particles using M2 fusion proteins for imaging single viruses and designing vaccines.
    Wei HJ; Chang W; Lin SC; Liu WC; Chang DK; Chong P; Wu SC
    Vaccine; 2011 Sep; 29(41):7163-72. PubMed ID: 21651946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza virus hemagglutinin and neuraminidase, but not the matrix protein, are required for assembly and budding of plasmid-derived virus-like particles.
    Chen BJ; Leser GP; Morita E; Lamb RA
    J Virol; 2007 Jul; 81(13):7111-23. PubMed ID: 17475660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and self-assembly of HCV structural proteins into virus-like particles and their immunogenicity.
    Zhao W; Liao GY; Jiang YJ; Jiang SD
    Chin Med J (Engl); 2004 Aug; 117(8):1217-22. PubMed ID: 15361298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of virus-like particles from human cell lines exclusively expressing influenza neuraminidase.
    Lai JC; Chan WW; Kien F; Nicholls JM; Peiris JS; Garcia JM
    J Gen Virol; 2010 Sep; 91(Pt 9):2322-30. PubMed ID: 20505010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses.
    Mahmood K; Bright RA; Mytle N; Carter DM; Crevar CJ; Achenbach JE; Heaton PM; Tumpey TM; Ross TM
    Vaccine; 2008 Oct; 26(42):5393-9. PubMed ID: 18706956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane-anchored incorporation of a foreign protein in recombinant influenza virions.
    Zhou Y; König M; Hobom G; Neumeier E
    Virology; 1998 Jun; 246(1):83-94. PubMed ID: 9656996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Achievement of avian influenza virus-like particles that could be used as a subunit vaccine against low-pathogenic avian influenza strains in ducks.
    Prel A; Le Gall-Reculé G; Jestin V
    Avian Pathol; 2008 Oct; 37(5):513-20. PubMed ID: 18798027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mutation on influenza C virus M1 protein affects virion morphology by altering the membrane affinity of the protein.
    Muraki Y; Murata T; Takashita E; Matsuzaki Y; Sugawara K; Hongo S
    J Virol; 2007 Aug; 81(16):8766-73. PubMed ID: 17537859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased incorporation of chimeric human immunodeficiency virus type 1 gp120 proteins into Pr55gag virus-like particles by an Epstein-Barr virus gp220/350-derived transmembrane domain.
    Deml L; Kratochwil G; Osterrieder N; Knüchel R; Wolf H; Wagner R
    Virology; 1997 Aug; 235(1):10-25. PubMed ID: 9300033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The M1 and M2 proteins of influenza A virus are important determinants in filamentous particle formation.
    Roberts PC; Lamb RA; Compans RW
    Virology; 1998 Jan; 240(1):127-37. PubMed ID: 9448697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production and characterization of mammalian virus-like particles from modified vaccinia virus Ankara vectors expressing influenza H5N1 hemagglutinin and neuraminidase.
    Schmeisser F; Adamo JE; Blumberg B; Friedman R; Muller J; Soto J; Weir JP
    Vaccine; 2012 May; 30(23):3413-22. PubMed ID: 22465746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paramyxovirus Sendai virus-like particle formation by expression of multiple viral proteins and acceleration of its release by C protein.
    Sugahara F; Uchiyama T; Watanabe H; Shimazu Y; Kuwayama M; Fujii Y; Kiyotani K; Adachi A; Kohno N; Yoshida T; Sakaguchi T
    Virology; 2004 Jul; 325(1):1-10. PubMed ID: 15231380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bovine leukemia virus Gag particle assembly in insect cells: formation of chimeric particles by domain-switched leukemia/lentivirus Gag polyprotein.
    Kakker NK; Mikhailov MV; Nermut MV; Burny A; Roy P
    Virology; 1999 Dec; 265(2):308-18. PubMed ID: 10600602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza-pseudotyped Gag virus-like particle vaccines provide broad protection against highly pathogenic avian influenza challenge.
    Haynes JR; Dokken L; Wiley JA; Cawthon AG; Bigger J; Harmsen AG; Richardson C
    Vaccine; 2009 Jan; 27(4):530-41. PubMed ID: 19026705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of antibody to the influenza A virus M2 protein on M2 surface expression and virus assembly.
    Hughey PG; Roberts PC; Holsinger LJ; Zebedee SL; Lamb RA; Compans RW
    Virology; 1995 Oct; 212(2):411-21. PubMed ID: 7571410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.